JP Morgan Chase’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.9M Buy
99,391
+45,272
+84% +$13M ﹤0.01% 1839
2025
Q4
$16.4M Sell
54,119
-2,131
-4% -$665K ﹤0.01% 2234
2025
Q3
$15.8M Buy
56,250
+2,519
+5% +$685K ﹤0.01% 2295
2025
Q2
$13M Sell
53,731
-3,512
-6% -$830K ﹤0.01% 2320
2025
Q1
$13.9M Buy
57,243
+10,095
+21% +$3.04M ﹤0.01% 2248
2024
Q4
$15.5M Sell
47,148
-6,988
-13% -$2.37M ﹤0.01% 2276
2024
Q3
$18.1M Sell
54,136
-4,840
-8% -$1.54M ﹤0.01% 2074
2024
Q2
$16.1M Buy
58,976
+20,765
+54% +$6.04M ﹤0.01% 2034
2024
Q1
$13.2M Sell
38,211
-8,153
-18% -$2.68M ﹤0.01% 2234
2023
Q4
$15M Buy
46,364
+8,469
+22% +$2.65M ﹤0.01% 2092
2023
Q3
$13.6M Sell
37,895
-5,698
-13% -$2.2M ﹤0.01% 1996
2023
Q2
$16.5M Buy
43,593
+1,243
+3% +$506K ﹤0.01% 1843
2023
Q1
$20.3M Buy
42,350
+9,179
+28% +$4.3M ﹤0.01% 1651
2022
Q4
$13.9M Sell
33,171
-5,131
-13% -$2.07M ﹤0.01% 1952
2022
Q3
$16M Sell
38,302
-3,662
-9% -$1.83M ﹤0.01% 1750
2022
Q2
$20.8M Buy
41,964
+4,929
+13% +$2.57M ﹤0.01% 1590
2022
Q1
$20.9M Buy
37,035
+6,296
+20% +$3.8M ﹤0.01% 1735
2021
Q4
$23.2M Buy
30,739
+573
+2% +$429K ﹤0.01% 1699
2021
Q3
$22.5M Sell
30,166
-21,292
-41% -$15.9M ﹤0.01% 1669
2021
Q2
$33.2M Buy
51,458
+19,901
+63% +$12.1M ﹤0.01% 1440
2021
Q1
$18M Sell
31,557
-18,217
-37% -$10.8M ﹤0.01% 1849
2020
Q4
$29M Buy
49,774
+2,110
+4% +$1.2M ﹤0.01% 1358
2020
Q3
$24.6M Buy
47,664
+10,928
+30% +$5.54M ﹤0.01% 1356
2020
Q2
$16.6M Sell
36,736
-8,066
-18% -$3.56M ﹤0.01% 1504
2020
Q1
$15.7M Sell
44,802
-1,678
-4% -$617K ﹤0.01% 1416
2019
Q4
$17.2M Sell
46,480
-14,465
-24% -$5.1M ﹤0.01% 1707
2019
Q3
$20.3M Buy
60,945
+16,960
+39% +$5.53M ﹤0.01% 1571
2019
Q2
$13.5M Sell
43,985
-6,526
-13% -$1.95M ﹤0.01% 1869
2019
Q1
$15.4M Buy
50,511
+5,122
+11% +$1.38M ﹤0.01% 1726
2018
Q4
$10.5M Buy
45,389
+1,532
+3% +$411K ﹤0.01% 1968
2018
Q3
$13.7M Buy
43,857
+13,398
+44% +$4.16M ﹤0.01% 1947
2018
Q2
$8.79M Sell
30,459
-6,658
-18% -$1.84M ﹤0.01% 2250
2018
Q1
$9.28M Sell
37,117
-7,482
-17% -$1.91M ﹤0.01% 2077
2017
Q4
$10.6M Buy
44,599
+13,744
+45% +$3.33M ﹤0.01% 2072
2017
Q3
$6.86M Buy
30,855
+5,823
+23% +$1.31M ﹤0.01% 2303
2017
Q2
$5.67M Buy
25,032
+15,374
+159% +$3.35M ﹤0.01% 2391
2017
Q1
$1.93M Buy
9,658
+9,008
+1,386% +$1.74M ﹤0.01% 3057
2016
Q4
$118K Sell
650
-4,756
-88% -$811K ﹤0.01% 4351
2016
Q3
$886K Sell
5,406
-9,051
-63% -$1.37M ﹤0.01% 3190
2016
Q2
$2.07M Sell
14,457
-18,922
-57% -$2.7M ﹤0.01% 2786
2016
Q1
$4.56M Buy
33,379
+17,719
+113% +$2.33M ﹤0.01% 2273
2015
Q4
$2.17M Sell
15,660
-20,476
-57% -$2.84M ﹤0.01% 2714
2015
Q3
$4.85M Sell
36,136
-28,921
-44% -$4.16M ﹤0.01% 2241
2015
Q2
$9.8M Buy
65,057
+24,288
+60% +$3.47M ﹤0.01% 1937
2015
Q1
$5.51M Buy
40,769
+27,111
+198% +$3.36M ﹤0.01% 2286
2014
Q4
$1.65M Sell
13,658
-39,581
-74% -$4.56M ﹤0.01% 3074
2014
Q3
$6.04M Buy
53,239
+34,676
+187% +$4.11M ﹤0.01% 2241
2014
Q2
$2.22M Sell
18,563
-6,187
-25% -$755K ﹤0.01% 2476
2014
Q1
$3.17M Buy
24,750
+3,754
+18% +$481K ﹤0.01% 2329
2013
Q4
$2.6M Buy
20,996
+2,416
+13% +$294K ﹤0.01% 2589
2013
Q3
$2.19M Buy
18,580
+498
+3% +$58.7K ﹤0.01% 2753
2013
Q2
$2.03M Buy
+18,082
New +$2.12M ﹤0.01% 2790

Other funds holding BIO